FAS Wealth Partners’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $782K | Buy |
7,281
+15
| +0.2% | +$1.61K | 0.06% | 180 |
|
|
2025
Q1 | $733K | Hold |
7,266
| – | – | 0.06% | 172 |
|
|
2024
Q4 | $649K | Sell |
7,266
-14,235
| -66% | -$1.27M | 0.05% | 182 |
|
|
2024
Q3 | $1.8M | Buy |
21,501
+14,235
| +196% | +$1.19M | 0.14% | 122 |
|
|
2024
Q2 | $560K | Hold |
7,266
| – | – | 0.05% | 194 |
|
|
2024
Q1 | $498K | Buy |
7,266
+137
| +2% | +$9.38K | 0.04% | 207 |
|
|
2023
Q4 | $412K | Hold |
7,129
| – | – | 0.04% | 214 |
|
|
2023
Q3 | $376K | Buy |
7,129
+285
| +4% | +$15K | 0.04% | 213 |
|
|
2023
Q2 | $370K | Buy |
6,844
+135
| +2% | +$7.3K | 0.05% | 194 |
|
|
2023
Q1 | $336K | Hold |
6,709
| – | – | 0.04% | 224 |
|
|
2022
Q4 | $310K | Sell |
6,709
-96
| -1% | -$4.44K | 0.04% | 238 |
|
|
2022
Q3 | $264K | Sell |
6,805
-5,807
| -46% | -$225K | 0.03% | 241 |
|
|
2022
Q2 | $470K | Buy |
+12,612
| New | +$470K | 0.05% | 189 |
|